Latest News

Filters

Filter by tags: United States Netherlands Rosatom Clear all tag filters

7 news articles found


Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

A consignment of Russian equipment has been delivered to the construction site of the International Thermonuclear Experimental Reactor (ITER) under construction at Cadarache in France, Russian state nuclear corporation Rosatom said on 23 April.

Date: Thursday, 30 April 2020
Original article: neimagazine.com/news/newsiter-receives-equipment-from-russia-and-italy-7892298

Sergey Kiriyenko, director general of Russian state nuclear corporation Rosatom, told journalists at the International Forum ATOMEXPO 2016 in Moscow on 31 May that the 10-year portfolio of Rosatom's orders for construction of NPPs will increase in 2016. "At the end of 2015, the order portfolio was $110bn. The 2016 we plan to finish at $136bn," he said, adding that 34 Russian design NPP units were now under construction in different regions of the world. He added that the cumulative portfolio of orders, including construction of NPPs, fuel supplies, uranium products delivery, services etc., exceeded $300bn.

Date: Tuesday, 07 June 2016
Original article: neimagazine.com/news/newsrosatom-signs-wide-ranging-deals-at-atomexpo-4915821


Russian state nuclear corporation Rosatom in 2016 will contribute RUB24.6m ($300,000) from its state budget allocation to the International Atomic Energy Agency's (IAEA's) International Project on Innovative Nuclear Reactors and Fuel Cycles (INPRO project), according to a Russian government directive published on the official legal information portal. The directive says Rosatom and the Russian Foreign Ministry will monitor the use of the Russian contribution.

Date: Thursday, 28 January 2016
Original article: neimagazine.com/news/newsrussia-contributes-to-iaea-inpro-project-4795612

The events at Fukushima Daiichi nuclear power station in Japan have already impacted nuclear policies worldwide. Germany has shut down its oldest nuclear plants for a safety review. China and Switzerland have suspended the approval processes to build new reactors and safety reviews have been ordered in many countries.

Date: Friday, 18 March 2011
Original article: neimagazine.com/news/newsinternational-impact-of-fukushima-daiichi-emergency